Detailed answers about KINETIC BIOPHARMA CONSULTANCY LIMITED, including incorporation, status, business activity, and accounts information.
When was KINETIC BIOPHARMA CONSULTANCY LIMITED founded?
KINETIC BIOPHARMA CONSULTANCY LIMITED was officially incorporated on 24 January 2025 and is registered under company number 16206969. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KINETIC BIOPHARMA CONSULTANCY LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KINETIC BIOPHARMA CONSULTANCY LIMITED?
KINETIC BIOPHARMA CONSULTANCY LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KINETIC BIOPHARMA CONSULTANCY LIMITED do?
KINETIC BIOPHARMA CONSULTANCY LIMITED operates in the following sectors: 70229 - Management consultancy activities other than financial management, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is KINETIC BIOPHARMA CONSULTANCY LIMITED's registered address?
The registered office address of KINETIC BIOPHARMA CONSULTANCY LIMITED is 167 - 169 GREAT PORTLAND STREET, 5TH FLOOR, LONDON, ENGLAND, W1W 5PF. This is the official address filed with Companies House for legal and statutory correspondence.
Is KINETIC BIOPHARMA CONSULTANCY LIMITED financially stable?
Financial accounts for KINETIC BIOPHARMA CONSULTANCY LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.